Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes
暂无分享,去创建一个
[1] B. Griffin. Relation of Burkitt's tumor‐associated herpes‐type virus to infectious mononucleosis , 1998, Reviews in medical virology.
[2] R. Herberman,et al. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. , 1977, Journal of immunology.
[3] D. Purtilo. PATHOGENESIS AND PHENOTYPES OF AN X-LINKED RECESSIVE LYMPHOPROLIPERATIVE SYNDROME , 1976, The Lancet.
[4] P. Parham,et al. Isolation and immunologic characterization of a human. B-lymphocyte- specific, cell surface antigen , 1976, The Journal of experimental medicine.
[5] H. Wigzell,et al. Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems , 1976, The Journal of experimental medicine.
[6] M. Jondal,et al. EBV‐determined nuclear antigen (EBNA)‐positive cells in the peripheral blood of infectious mononucleosis patients , 1976, International journal of cancer.
[7] T. Takemori,et al. Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization , 1975, The Journal of experimental medicine.
[8] J. Robinson. Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood , 1975, Journal of virology.
[9] M. Jondal,et al. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Macdermott,et al. Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone. , 1975, Journal of immunology.
[11] H. Hausen,et al. Epstein‐barr virus‐induced transformation of human leukocytes after cell fractionation , 1975, International journal of cancer.
[12] M. Epstein,et al. Observations on the nature of Epstein-Barr virus infection of peripheral lymphoid cells in infectious mononucleosis. , 1975, IARC scientific publications.
[13] M. Jondal. Surface Markers on Human B and T Lymphocytes , 1974, Scandinavian journal of immunology.
[14] J. H. Pope,et al. Cell relationships in transformation of human leukocytes by epstein‐barr virus , 1974, International journal of cancer.
[15] W. Knapp,et al. Independent movement of IgD and IgM molecules on the surface of individual lymphocytes. , 1973, Journal of immunology.
[16] G. Miller,et al. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Frøland,et al. Identification of Three Different Human Lymphocyte Populations by Surface Markers , 1973, Transplantation reviews.
[18] G. Klein,et al. Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.
[19] G. Miller,et al. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. , 1973, The New England journal of medicine.
[20] G. Miller,et al. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[21] V. Diehl,et al. Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. , 1972, Nature: New biology.
[22] M. Lohmann‐Matthes,et al. Macrophage‐mediated cytotoxicity against allogeneic target cells in vitro , 1972, European journal of immunology.
[23] G. Klein,et al. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. , 1971, Journal of the National Cancer Institute.
[24] L. Subrahmanyan,et al. Prevalence, incidence and persistence of EB virus antibody in young adults. , 1970, The New England journal of medicine.
[25] V. Diehl,et al. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. , 1969, Journal of the National Cancer Institute.
[26] V. Diehl,et al. Demonstration of a Herpes Group Virus in Cultures of Peripheral Leukocytes from Patients with Infectious Mononucleosis , 1968, Journal of virology.
[27] A. Böyum. Separation of leukocytes from blood and bone marrow. Introduction. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[28] R. Herberman,et al. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. , 1977, Journal of immunology.
[29] D. Purtilo. PATHOGENESIS AND PHENOTYPES OF AN X-LINKED RECESSIVE LYMPHOPROLIPERATIVE SYNDROME , 1976, The Lancet.
[30] P. Parham,et al. Isolation and immunologic characterization of a human. B-lymphocyte- specific, cell surface antigen , 1976, The Journal of experimental medicine.
[31] H. Wigzell,et al. Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems , 1976, The Journal of experimental medicine.
[32] M. Jondal,et al. EBV‐determined nuclear antigen (EBNA)‐positive cells in the peripheral blood of infectious mononucleosis patients , 1976, International journal of cancer.
[33] M. Feldmann,et al. Different Ly antigen phenotypes of in vitro induced helper and suppressor cells , 1975, Nature.
[34] T. Takemori,et al. Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization , 1975, The Journal of experimental medicine.
[35] J. Robinson. Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood , 1975, Journal of virology.
[36] M. Jondal,et al. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Greaves,et al. Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis , 1975 .
[38] R. Macdermott,et al. Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone. , 1975, Journal of immunology.
[39] H. Hausen,et al. Epstein‐barr virus‐induced transformation of human leukocytes after cell fractionation , 1975, International journal of cancer.
[40] M. Epstein,et al. Observations on the nature of Epstein-Barr virus infection of peripheral lymphoid cells in infectious mononucleosis. , 1975, IARC scientific publications.
[41] M. Jondal. Surface Markers on Human B and T Lymphocytes , 1974, Scandinavian journal of immunology.
[42] J. H. Pope,et al. Cell relationships in transformation of human leukocytes by epstein‐barr virus , 1974, International journal of cancer.
[43] G. Klein,et al. SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES , 1973, The Journal of experimental medicine.
[44] W. Knapp,et al. Independent movement of IgD and IgM molecules on the surface of individual lymphocytes. , 1973, Journal of immunology.
[45] G. Miller,et al. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Frøland,et al. Identification of Three Different Human Lymphocyte Populations by Surface Markers , 1973, Transplantation reviews.
[47] G. Klein,et al. Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.
[48] G. Miller,et al. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. , 1973, The New England journal of medicine.
[49] G. Miller,et al. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[50] H. Wigzell,et al. SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES , 1972, The Journal of experimental medicine.
[51] V. Diehl,et al. Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. , 1972, Nature: New biology.
[52] M. Lohmann‐Matthes,et al. Macrophage‐mediated cytotoxicity against allogeneic target cells in vitro , 1972, European journal of immunology.
[53] G. Klein,et al. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. , 1971, Journal of the National Cancer Institute.
[54] L. Subrahmanyan,et al. Prevalence, incidence and persistence of EB virus antibody in young adults. , 1970, The New England journal of medicine.
[55] V. Diehl,et al. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. , 1969, Journal of the National Cancer Institute.
[56] V. Diehl,et al. Demonstration of a Herpes Group Virus in Cultures of Peripheral Leukocytes from Patients with Infectious Mononucleosis , 1968, Journal of virology.
[57] A. Bøyum,et al. Separation of leukocytes from blood and bone marrow. Introduction. , 1968 .
[58] A. Böyum. Separation of leukocytes from blood and bone marrow. Introduction. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[59] V. Diehl,et al. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.